Condition: Primary Open Angle Glaucoma · Sponsor: Nova Eye, Inc.
A multicenter, randomized, clinical trial to evaluate the efficacy of canaloplasty performed as a standalone procedure using the iTrack™ Advance canaloplasty device (Nova Eye, Inc.) as compared to the OMNI® Surgical System (Sight Sciences) in patients with mild to moderate primary open-angle glaucoma.
This description comes directly from the study's public registry record.
Mike Pickrel · 1-800-391-2316 · mpickrel@nova-eye.com
Always discuss trial participation with your own doctor first.
| Breyer Kaymak Klabe Augenchirurgie | Düsseldorf, Germany | Recruiting |
| Hospital Clinico San Carlos, Servicio de Oftalmologia | Madrid, Spain | Recruiting |
| Princess Alexandra Eye Pavilion, NHS Lothian | Edinburgh, United Kingdom | Recruiting |
| St. Paul's Eye Unit, Liverpool University | Liverpool, United Kingdom | Recruiting |
| Manchester Royal Eye Hospital | Manchester, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05786196